Feinstein Institutes Get $3M From Lupus Research Alliance To Study Remission And Future Therapies
Aug 24, 2022•over 3 years ago
Amount Raised
$3 Million
Round Type
seed
Science And EngineeringHealth CareBiotechnology
Description
Millions worldwide and an estimated 200,000 people in the United States have lupus, of whom 90 percent are women. In an effort to translate basic molecular research into better therapy for patients seeking care, The Feinstein Institutes for Medical Research has been awarded a $3 million Global Team Science Award from the Lupus Research Alliance. Betty Diamond, MD, director of the Institute of Molecular Medicine at the Feinstein Institutes and the Maureen and Ralph Nappi Professor of Autoimmune Diseases, will lead the research efforts as the corresponding investigator with a multi-disciplinary global team.